We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+3.86%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$18.8B
AUM Growth
+$1.08B
Cap. Flow
+$375M
Cap. Flow %
1.99%
Top 10 Hldgs %
32.3%
Holding
1,384
New
65
Increased
662
Reduced
357
Closed
63

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$243M
2
PLD icon
Prologis
PLD
+$106M
3
DLR icon
Digital Realty Trust
DLR
+$97.4M
4
KIM icon
Kimco Realty
KIM
+$96.3M
5
SNOW icon
Snowflake
SNOW
+$88.7M

Top Sells

Rank Stock Value
1
O icon
Realty Income
O
+$225M
2
INVH icon
Invitation Homes
INVH
+$153M
3
EQIX icon
Equinix
EQIX
+$91.3M
4
SPG icon
Simon Property Group
SPG
+$91.1M
5
AMT icon
American Tower
AMT
+$91M

Sector Composition

Rank Sector Weight
1 Real Estate 42.05%
2 Technology 19.13%
3 Communication Services 6.55%
4 Consumer Discretionary 6.17%
5 Financials 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WVE icon
1251
Wave Life Sciences
WVE
$1.13B
$2K ﹤0.01%
349
XLP icon
1252
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$2K ﹤0.01%
+32
New +$2.44K
YMAB
1253
DELISTED
Y-mAbs Therapeutics
YMAB
$2K ﹤0.01%
162
ZYME icon
1254
Zymeworks
ZYME
$1.66B
$2K ﹤0.01%
286
PETQ
1255
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2K ﹤0.01%
99
ABUS icon
1256
Arbutus Biopharma
ABUS
$871M
$1K ﹤0.01%
395
ALEC icon
1257
Alector
ALEC
$169M
$1K ﹤0.01%
277
ALXO icon
1258
ALX Oncology
ALXO
$268M
$1K ﹤0.01%
138
AMLX icon
1259
Amylyx Pharmaceuticals
AMLX
$2.17B
$1K ﹤0.01%
266
AMRN
1260
Amarin Corp
AMRN
$293M
$1K ﹤0.01%
67
ATAI icon
1261
AtaiBeckley Inc
ATAI
$2.66B
$1K ﹤0.01%
468
AVIR icon
1262
Atea Pharmaceuticals
AVIR
$361M
$1K ﹤0.01%
242
AVXL icon
1263
Anavex Life Sciences
AVXL
$238M
$1K ﹤0.01%
314
CABA icon
1264
Cabaletta Bio
CABA
$445M
$1K ﹤0.01%
175
EDIT icon
1265
Editas Medicine
EDIT
$402M
$1K ﹤0.01%
277
-6,913
-96% -$39K
ERAS icon
1266
Erasca
ERAS
$6.3B
$1K ﹤0.01%
354
EYPT icon
1267
EyePoint Inc
EYPT
$1B
$1K ﹤0.01%
144
FULC icon
1268
Fulcrum Therapeutics
FULC
$248M
$1K ﹤0.01%
138
LKFT
1269
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$1K ﹤0.01%
51
HCM icon
1270
HUTCHMED
HCM
$1.93B
$1K ﹤0.01%
85
-100
-54% -$1.84K
HUMA icon
1271
Humacyte
HUMA
$170M
$1K ﹤0.01%
301
LYEL icon
1272
Lyell Immunopharma
LYEL
$318M
$1K ﹤0.01%
46
MGNX icon
1273
MacroGenics
MGNX
$245M
$1K ﹤0.01%
209
MGTX icon
1274
MeiraGTx Holdings
MGTX
$1.09B
$1K ﹤0.01%
130
MXCT icon
1275
MaxCyte
MXCT
$112M
$1K ﹤0.01%
293

Similar funds

Daiwa Securities Group's Q2 2024 Portfolio in Review

As of Q2 2024, Daiwa Securities Group held 1,384 positions worth $18.8B, up 6.1% from $17.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group's Q2 2024 filing shows 65 new, 662 increased, 357 reduced and 63 closed positions. Its largest new stake was NextEra Energy 7.299% Corporate Units: 500,000 shares worth $24.6M. The largest sale was Realty Income, an estimated $225M.

By sector, the portfolio is most concentrated in Real Estate at 42% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 500,000 shares worth $24.6M.
  • Daiwa Securities Group added most to Crown Castle in Q2 2024, an estimated $243M increase.
  • Daiwa Securities Group's biggest Q2 2024 reduction was Realty Income, cutting an estimated $225M.
  • Daiwa Securities Group fully exited Apartment Income REIT Corp. in Q2 2024, selling an estimated $88.4M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $18.8B portfolio in Q2 2024.
  • Daiwa Securities Group opened 65 new positions and closed 63 in Q2 2024.
  • Daiwa Securities Group's portfolio value rose 6.1% quarter-over-quarter to $18.8B.

Based on Daiwa Securities Group's 13F filing for Q2 2024, filed 7 Aug 2024.